Concepedia

Reliability of IDH1-R132H and ATRX and/or p53 immunohistochemistry for molecular subclassification of Grade 2/3 gliomas

Tomohide Nishikawa, Reiko Watanabe, Yotaro Kitano, Akane Yamamichi, Kazuya Motomura, Fumiharu Ohka, Kosuke Aoki, Masaki Hirano, Akira Kato, Junya Yamaguchi,

Brain Tumor Pathology · 2021 · 17 citations · 20 references

DOIFull text

Open access

Concepts

References

20

Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402

Gregory Cairncross, Meihua Wang, Edward Shaw et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text

, , +14

cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”

Daniel J. Brat, Kenneth Aldape, Howard Colman et al. · Acta Neuropathologica · 2018 · 906 citations

, , +15

Mutational landscape and clonal architecture in grade II and III gliomas

Hiromichi Suzuki, Kosuke Aoki, Kenichi Chiba et al. · Nature Genetics · 2015 · 847 citations

, , +17

cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading

David N. Louis, Pieter Wesseling, Kenneth Aldape et al. · Brain Pathology · 2020 · 534 citations · Full text

, , +13

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Daniel J. Brat, Kenneth Aldape, Howard Colman et al. · Acta Neuropathologica · 2020 · 530 citations

, , +15